The objective of this study is to evaluate disease progression, using multiple modalities, in subjects with genetically-confirmed STGD1.
This is a prospective, observational, non-interventional, multi-center, global clinical study of subjects with early to advanced stage STGD1 caused by bi-allelic likely pathogenic or pathogenic variants in the ABCA4 gene, confirmed genotypically by an ac
Have a diagnosis of STGD1 caused by bi-allelic likely pathogenic or pathogenic variants in the ABCA4 gene confirmed genotypically by an accredited genotyping laboratory.
Protocol Number: 24-0332
Principal Investigator